A team of researchers from five Swedish universities have made a remarkable breakthrough in the treatment of cancer, with an equally innovative source of funding.
“We are first to show this new way of targeting cancer and this is likely going to be the major path for drug development in the future,” said Thomas Helleday, holder of the Söderberg Professorship at Karolinska Institutet, who heads the study.
Until now, most modern anti-cancer drugs have been tailored to target the genetic makeup of the cancer – a so-called personalized treatment. Sometimes this can have a long-lasting effect, but more often than not the cancers mutate to become resistant. What the team has managed to do is to target an enzyme that is required for all cancer cells for survival, but that normal cells do not need.
Helleday explained that the treatment – which comes in the form of a pill – can kill any cancer and does not have any severe side effects.
“Some say our finding sounds too good to be true, and I understand their gut feeling after seeing so many promising cancer treatments fail,” he said. “My research group has made paradigm shifts before and to those skeptics I say: just sit back and enjoy the revolution!”
What’s also revolutionary is the way the research is financed, through “open innovation” and “crowd sourcing”.
“I started a public foundation that owns all intellectual property and the idea is that we manufacture large amounts of the drug and provide it for free to the worldwide academic community, so they can design their own clinical trials and run them”, Helleday said.
“Also, as there is a public foundation behind the drug, it will not be used to enrich a few individuals, but be used for further work on new medicines.”
A lot of work remains to be done before it is time for clinical trials, which are still a year or two away, Helleday said.
Being based in Stockholm brings many advantages, including a number of highly trained drug developers looking for new challenges, he said.
“A major point is that Swedish Universities do not claim or take control on intellectual property, allowing us to donate it to a public foundation,” Helleday said.
“Another advantage is the collaborative nature of Swedes. We collaborated with five different universities to progress the project, which would have been difficult elsewhere.”
Their concept is presented in two articles in science journal Nature, with the aim of spreading the word to as many as possible in the research community.
“It has generated interest from academics across the world, to try the new concept on the cancer indication they have specialized in,” Helleday said.
The team has also sent out the compound to hundreds of scientists across the globe in an effort to increase the speed of innovation and to reach the goal of curing cancer more quickly. By freely sending out compounds, they have increased competition.
“Hundreds of scientists are advancing more quickly than one and we increase the chances of overall success,” Helleday said.
The Latest on: Cancer breakthrough
via Google News
The Latest on: Cancer breakthrough
- Data on Amgen’s KRAS-blocking cancer drug are encouraging, but also raise new questionson September 8, 2019 at 12:51 am
Last June, Amgen (AMGN) excited cancer scientists and investors alike with the first ... policy developments in Washington, early science breakthroughs and clinical trial results, and health care ...
- Former Cardinals' World Series Winner Chris Duncan Dies of Brain Cancer at 38on September 6, 2019 at 6:54 pm
The Cardinals won the National League wild-card in Duncan's breakthrough season before winning the World ... Duncan was initially diagnosed with brian cancer in 2012, and he took a leave of absence in ...
- Prostate Cancer Treatment – High Intensity Focused Ultrasoundon September 6, 2019 at 12:18 pm
prostate cancer is the most common cancer among men. Thanks to technology there's been a breakthrough in treating this disease. It's called High Intensity Focused Ultrasound. For more ...
- New Drug Screening Tool for Cancer Research Comes to Marketon September 6, 2019 at 11:49 am
“While our researchers have made some incredible discoveries in the lab, the real breakthrough will happen once cancer patients are more effectively treated using the precisely targeted therapeutic ...
- Novartis' Capmatinib Gets Breakthrough Therapy Tag From FDAon September 6, 2019 at 9:40 am
Novartis AG NVS announced that the FDA has granted a Breakthrough Therapy designation ... MET exon14 skipping-mutated non-small cell lung cancer (NSCLC). Currently, there is no approved therapy ...
- Novartis wins FDA's breakthrough tag for lung cancer hopefulon September 5, 2019 at 10:39 pm
ZURICH (Reuters) - Novartis has secured the U.S. Food and Drug Administration’s Breakthrough Therapy Designation for its investigational medicine capmatinib, which it aims to file for approval later ...
- Novartis joins Pfizer with FDA fast-track tag for lung cancer hopefulon September 5, 2019 at 10:37 pm
ZURICH (Reuters) - Novartis has nabbed the U.S. Food and Drug Administration's breakthrough therapy designation for its experimental medicine capmatinib as it joins Pfizer in the race to treat a tough ...
- Neon Therapeutics Announces Publication in Immunity of Novel Approach to Predict MHC Class II Cancer-Specific Neoantigenson September 5, 2019 at 5:35 pm
Predicting the relevant cancer-specific antigens is a crucial precursor to developing immunotherapies that effectively train T cells to traffic to the tumor and destroy malignant cells.
- Breakthrough Prizes for scientists: $22 million effort to elevate them and their workon September 5, 2019 at 3:00 pm
On Nov. 3, Julius will receive a 2020 Breakthrough Prize, which this year awards $22 million ... supports protein folding and prevents protein aggregation, which can lead to cancer and ...
- Scientists Behind First Black Hole Image Win $3 Million Breakthrough Prize Awardon September 5, 2019 at 12:10 pm
The Breakthrough Prize Foundation has awarded ... Mirzakhani passed away in 2017 from breast cancer. The four prizes for life sciences will go to scientists for a slew of discoveries.
via Bing News